Nonetheless, more in‐depth research is warranted to shed more light on how the regulation of aberrant SWI/SNF complexes affects the immune microenvironment of HCC and to lay a foundation for the novel immunotherapies. This evidence concerns the gene SMARCA1 and hepatocellular carcinoma.